Prot #M21-341: A Phase 2/3 Multicenter, Double Blinded, Randomized, Dose- Conversion, Active Control Study Examining the Efficacy and Safety of Armour Thyroid Compared to Synthetic T4 for the Treatment of Adults with Primary Hypothyroidism